UCB Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:UCB Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10908
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
UCB Inc (UCB), a subsidiary of UCB SA, is a healthcare solutions provider that offers therapeutics. The company develops products with an emphasis on central nervous system and immunology therapeutic domains. Its products include cimzia, vimpat, keppra XR, neupro, tussionex pennkinetic, metadate CD, and others. UCB’s products are used in the treatment of partial onset seizures, rheumatoid arthritis, attention deficit hyperactivity disorder and cough and upper respiratory symptoms associated with allergy or a cold. The company also conducts research and development to upgrade its products according to market requirements. It offers several health programs for patients, healthcare professionals and caregivers. The company operates through research triangle park located in North Carolina. UCB is headquartered in Smyrna, Georgia, the US.

UCB Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
UCB Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UCB Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
UCB Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UCB Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
UCB Inc, Medical Devices Deals, 2012 to YTD 2018 9
UCB Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
UCB Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Clementia Pharma Secures USD60 Million Venture Financing 11
Partnerships 13
Evotec Partners with UCB 13
Vectura Enters Into Co-Development Agreement With UCB For Biologic Immunomodulatory Product 14
Licensing Agreements 15
UCB Exercises Option for Licensing Agreement with Oncodesign 15
UCB Enters Into Licensing Agreement With Medical Research Council Technology For Fibrosis Program 16
UCB Inc – Key Competitors 17
UCB Inc – Key Employees 18
UCB Inc – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
UCB Inc, Pharmaceuticals & Healthcare, Key Facts 2
UCB Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UCB Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
UCB Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UCB Inc, Deals By Therapy Area, 2012 to YTD 2018 8
UCB Inc, Medical Devices Deals, 2012 to YTD 2018 9
UCB Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Clementia Pharma Secures USD60 Million Venture Financing 11
Evotec Partners with UCB 13
Vectura Enters Into Co-Development Agreement With UCB For Biologic Immunomodulatory Product 14
UCB Exercises Option for Licensing Agreement with Oncodesign 15
UCB Enters Into Licensing Agreement With Medical Research Council Technology For Fibrosis Program 16
UCB Inc, Key Competitors 17
UCB Inc, Key Employees 18

List of Figures
UCB Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
UCB Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
UCB Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
UCB Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
UCB Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UCB Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
UCB Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UCB Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
UCB Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[UCB Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cascal N.V.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Cascal N.V. Mergers and Acquisi …
  • Daiichi Kigenso Kagaku Kogyo Co., Ltd. (4082):企業の財務及び戦略的SWOT分析
    Summary Daiichi Kigenso Kagaku Kogyo Co., Ltd. (DKKK) is a chemical company that manufactures and sells zirconium compounds and other chemical products to its customers. Its product categories include zirconium oxide, stabilized zirconium oxide, composite oxide, zirconium compounds, zirconia sol, ra …
  • Accel Frontline Limited (AFL):企業概要、財務及び戦略的SWOT分析
    Summary Accel Frontline Limited (AFL) is an information technology company. The company provides integrated IT services to small, medium, and large enterprises. It offers engineering and research and development services, enterprise application services, IT infrastructure services and auxiliary serv …
  • VLS Finance Ltd. (VLSFINANCE):企業の財務及び戦略的SWOT分析
    Summary VLS Finance Ltd. (VLS) is a non banking finance company that offers financial services to the corporate and institutional clients. The company’s financial services include asset management, strategic private equity investments and arbitrage. It also offers services such as investment banking …
  • Bio3 Research Srl-製薬・医療分野:企業M&A・提携分析
    Summary Bio3 Research Srl (Bio3 Research) is a biopharmaceutical company that undertakes the identification and development of therapeutic agents for diseases related to HMGB1 protein over-expression and HMGB1 biological properties. The company develops proprietary compounds with therapeutic potenti …
  • Arcapita Bank B.S.C.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Arcapita Bank B.S.C. Mergers an …
  • New Standard Energy Limited (NSE):企業の財務及び戦略的SWOT分析
    Summary New Standard Energy Limited (NSE) is an oil and gas exploration company that produces, develops and explores oil and gas. The company has onshore oil and gas exploration assets in the Canning Basin in the north-west of Western Australia. NSE undertakes projects such as Eagle Ford acreage is …
  • Shibuya Kogyo Co., Ltd.:企業の戦略・SWOT・財務分析
    SummaryShibuya Kogyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Poslovni sistem Mercator, d.d.:戦略・SWOT・企業財務分析
    Poslovni sistem Mercator, d.d. - Strategy, SWOT and Corporate Finance Report Summary Poslovni sistem Mercator, d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Vattenfall:企業の戦略・SWOT・財務情報
    Vattenfall - Strategy, SWOT and Corporate Finance Report Summary Vattenfall - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Mitsui Chemicals, Inc.:企業の戦略・SWOT・財務情報
    Mitsui Chemicals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mitsui Chemicals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cellnovo Ltd.:(医療機器分野)企業M&A及び提携動向
    Summary Cellnovo Ltd. (Cellnovo) is a biomedical device company. The company develops and manufactures innovative mobile diabetes management system. It offers insulin pumps that connect wirelessly to an app-based touch-screen handset. Cellnovo products enable users to access journals, manage insulin …
  • Energie Beheer Nederland B.V.:企業の戦略的SWOT分析
    Summary Energie Beheer Nederland B.V. (EBN) is an state owned energy company. It is engaged in the exploration, production, and sale of oil and natural gas. It is also engaged in related activities such as transport and storage. In addition, the company advises the government on energy policy. EBN i …
  • Spirig Pharma AG(製薬・医療分野):企業M&A動向
    Summary Spirig Pharma AG (Spirig Pharma) is a pharmaceutical company. The company research, develops, manufactures and markets dermatological and generic products. Its products include skin disorder products, sun protection, and solar damage products. Spirig Pharma offers products under brand names …
  • Ironwood Pharmaceuticals, Inc.:企業のM&A・提携・投資分析
    Ironwood Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ironwood Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • PetroChina Company Limited (857):企業のM&A・提携動向(エネルギー分野)
    Summary PetroChina Company Limited (PetroChina) is an oil and gas company that explores for, develops and produces crude oil and natural gas; refines crude oil and petroleum products; and produces and sells basic and derivative chemical products and other chemical products. It also markets and trade …
  • Foundation for Innovative New Diagnostics-医療機器分野:企業M&A・提携分析
    Summary Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured …
  • Katrina Group Ltd. (1A0):企業の財務・戦略的SWOT分析
    Katrina Group Ltd. (1A0) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Diamondback Energy, Inc.(石油・ガス分野):企業M&A動向
    Summary Diamondback Energy, Inc. (Diamondback Energy) is an oil and gas exploration company. It acquires, develops, explores and exploits unconventional, long-life, onshore oil and natural gas reserves in Permian Basin in West Texas. The company focuses on improving the reserves and production throu …
  • Jack in the Box, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Jack in the Box, Inc. Mergers a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆